The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 03, 2019
Filed:
Dec. 28, 2017
Applicant:
Biogen Inc., Cambridge, MA (US);
Inventors:
Christine A. White, Rancho Santa Fe, CA (US);
Antonio J. Grillo-Lopez, Rancho Santa Fe, CA (US);
Assignee:
Biogen, Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/573 (2006.01); A61K 31/704 (2006.01); A61K 31/664 (2006.01); C07K 16/28 (2006.01); A61K 31/475 (2006.01); A61K 31/675 (2006.01); A61K 35/28 (2015.01); A61K 35/545 (2015.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2887 (2013.01); A61K 31/475 (2013.01); A61K 31/573 (2013.01); A61K 31/664 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 35/28 (2013.01); A61K 35/545 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); Y10S 424/801 (2013.01);
Abstract
The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.